In this episode we talk to Dylan Roskams-Edris from Open Science Alliance Officer at Tanenbaum Open Science Institute and The Neuro in Canada. We discussed how The Neuro made itself into the worlds first open neuroscience institution, the challenges and opportunities of embracing Open Science at an institutional level, how Open Science itself needs to be more open, and the potential for scientists working in such a system.
In this episode we talk to Professor Stefano Bertozzi, editor-in-chief Rapid Reviews: COVID-19 (RR:C19). This new open access overlay journal from the MIT Press is aiming to publish expert peer reviews of new COVID-19 research which will help validate and accelerate the discovery of high impact, useful studies. We discussed how the journal will work, the role human and AI input will play, and the importance of pan-disciplinary content.
In this episode we cover UniStem Day, a pan European outreach event that bring stem cell research and high school students together. We talk to the organisers of UniStem Day at the Max-Delbrück-Center for Molecular Medicine, Stefanie Mahler and Dr Daniel Besser, as well as teachers and pupils who attended.
German Stem Cell Network
CC 0, CC BY or CC BY-NC-SA? We talked to Cable Green, the interim CEO and Director of Open Education at Creative Commons. Cable explained the rationale behind the licenses on digital work and provided us with a practical guide to how to use these. Further on, we ventured into the world of Open Education and how it is empowered by Creative Commons licensing. And yes - we did also talk about Covid-19 and how it is changing the way we think about open access and collaboration.
One of the issues that gets raised by the Open Science movement is that it has a potential conflict with innovation and commercialisation of research. To explore this topic we talked to Professor Shobita Parthasarathy about how patents actually work, how we understand the idea of science as a public good, and the challenges of inclusive innovative.
Science, Technology, and Public Policy Program
Shobita Parthasarathy. Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care. Cambridge, MA: MIT Press, 2007. (available at Amazon, MIT Press, and wherever books are sold)
Shobita Parthasarathy. Patent Politics: Life Forms, Markets, and the Public Interest in the United States and Europe. Chicago: University of Chicago Press, 2017 (available at Amazon, University of Chicago Press, and wherever books are sold)
Shobita Parthasarathy. “Use Patents to Regulate Gene Editing.” Nature. October 25, 2018.
Shobita Parthasarathy. “An early expression of democracy, the US patent system is out of step with today’s citizens.” [Updated]. The Conversation. July 4 2018. (reprinted in Business Insider, Associated Press, among other outlets)
Shobita Parthasarathy. “How to make sure we all benefit when nonprofits patent technologies like CRISPR.” The Conversation. July 19, 2017.
In this episode we talk to Dr Brian Nosek about the work of the Center for Open Science. We discuss how to shift expectations of what is the norm is science, preregistration, networks, and the impact of a digital society on scientific practice.
Center for Open Science
This week we talk to Lara Mangravite, President of Sage Bionetworks 'a nonprofit biomedical research and technology development organization' that facilitates research data sharing in biomedicine, as well as promoting community research and citizen science projects. We discussed the advantages and challenges of dating sharing and what tools Sage BioNetworks are offering*.
Episode Links (provided by Sage Bionetworks):
Synapse is a set of web services and tools created by Sage Bionetworks that make it easier for researchers to aggregate, organize, analyze, and share scientific data, code, and insights. mPower is a free, 2 year digital health research study developed with the goal of understanding the progression of Parkinson’s Disease at the level of the individual. Elements of Informed Consent is a free, downloadable toolkit for researchers that includes basic information and best practices for developing an effective informed consent process. The Open Drug Discovery Center for AD (Open AD) was established to develop and openly distribute experimental tools for use in the evaluation of a diverse set of novel AD targets.
Center for Open Science , NIH All of Us Research Program, Structural Genomics Consortium
*"The thoughts and views expressed in this interview are Lara Mangravite's and not those of Sage Bionetworks or any affiliated organizations."
Season 2 is here! We start by looking back at the last year, and talking for the first time about the Open Science project that we are part of ORION. In particular, we consider the aim and impact of Open Science training and interview two participants: Malte Schäfer from TU Braunschweig and Dr Deirdre Winrow from University College Dublin, from our workshop and our MOOC.
"He radicalised me"
"It gives them space to reflect on Open Science"
"The system of science has changed"
In the last episode of 2019 we talk to Professor Dan Quintana from the University of Oslo about the advantages of sharing preprints and ideas online, fears about getting scooped, and lessons he has learnt about Twitter and time management.
Everything Hertz Podcast
Physiology & Behavior Podcast
"The great thing about social media is it is a great way to organise a lot of people who are like-minded"